nach oben

Abdominal Radiology

Erschienen in:

20.02.2020 | Perspective

Imaging for prostate cancer: reimbursements

verfasst von: Connor Hoge, Abhinav Sidana, Sadhna Verma

Erschienen in: Abdominal Radiology | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Excerpt

Multiparametric magnetic resonance imaging (mpMRI) has become an integral part of management of patients with prostate cancer (PCa) over the last decade. MpMRI has proven to improve detection, localization, and characterization of prostate malignancy [1, 2]. Fused with ultrasound imaging, it also assists in more accurate biopsy targeting. However, obtaining insurance reimbursement of mpMRI can still be a challenge and is often restricted to only certain clinical criteria. …

Turkbey B, Brown AM, Sankineni S, et al (2015). Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer. CA Cancer J Clin 00:00-00.

Radtke JP, Schwab C, Wolf MB, et al (2016). Multiparametric magnetic resonance imaging (MRI) and MRI-transrectal ultrasound fusion biopsy for index tumor detection: correlation with radical prostatectomy specimen. Eur Urol. Nov 70(5):846-853.

El- Shater Bosaily A, Parker C, Brown LC, et al (2015). PROMIS-Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer. Contemp Clin Trials. 42:26-40.CrossRefPubMedPubMedCentral

Bjurlin MA, Carroll PR, Eggener S, et al (2019). Update of the standard operating procedure on the use of multiparametric magnetic resonance imaging for the diagnosis, staging, and management of prostate cancer. J Urol. 101097JU0000000000000617.

Sidana A, Watson MJ, George AK, et al (2018). Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: a multi-institutional analysis. Urol Onc. Jul;36(7):341.e1-341.e7

Wegelin O, Exterkate L, van der Leest M et al (2019). The FUTURE trial: a multicenter randomized controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with prior negative biopsies. Eur Urol. 75: 582-590/

Sonn GA, Chang E, Natarajan et al (2014). Value of targeted biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol. 65:809-815.CrossRefPubMed

Valerio M, Donaldson I, Emberton M et al (2015). Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review. Eur Urol. 68:8-19.CrossRefPubMed

Shah TT, Peters M, Eldred-Evans D, et al (2019). Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry. Eur Urol. 76(1):98-105.CrossRefPubMed

10.

Guillaumier S, Peters M, Arya M, et al (2018). A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer. Eur Urol. 74(4):422-429CrossRefPubMedPubMedCentral

11.

van den Bergh RC, Ahmed HU, Bangma CH et al (2014). Novel tools to improve patient selection and monitoring on active surveillance for prostate cancer: a systematic review. Eur Urol. 65(6): 1023-31.CrossRef

12.

Guo R, Cai L, Fan Y et al (2015). Magnetic resonance imaging on disease reclassification among active surveillance candidates with low-risk prostate cancer: a diagnostic meta-analysis. Prostate Cancer Prostatic Dis. May; 18: 221–228. https://doi.org/10.1038/pcan.2015.20

13.

Rosenkrantz AB, Verma S, Choyke P et al (2016). Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement of the American Urological Association and the Society of Abdominal Radiology’s Prostate Cancer Diseases Focused Panel. J Urol. Dec; 196 (6): 1613-1618.

14.

Mohler JL, Antonarakis ES, Armstrong AJ et al (2019). Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. May; 17:479–505

15.

Booker MT, Silva E 3rd, Rosenkrantz AB (2019). National Private Payer Coverage of Prostate MRI. J Am Coll Radiol. 16(1):24-29.CrossRefPubMed

16.

Rosenkrantz AB, Lepor H, Huang WC, Taneja SS (2016). Practical Barriers to Obtaining Pre-Biopsy Prostate MRI: Assessment in Over 1,500 Consecutive Men Undergoing Prostate Biopsy in a Single Urologic Practice. Urol Int. 97(2):247-248.CrossRefPubMed

17.

Rosenkrantz AB (2014). Regional variation in medicare imaging utilization and expenditures: 2007-2011 trends and comparison with other health services. J AM Coll Radiol. Jan;11(1):45-50.

18.

Rosenkrantz AB, Chu S, Choyke PL et al (2019). Prostate MRI model policy. American College of Radiology. https://www.acr.org/-/media/ACR/Files/Advocacy/AIA/Prostate-MRI-Model-Policy72219.pdf. Accessed 25 December 2019.

19.

Rosenkrantz AB, Degnan AJ, Duszak R (2018). Documentation, coding, and billing: what abdominal radiologists need to know. Abdom Radiol. 43(3):734-741.CrossRef

20.

What is MRI with Transrectal Ultrasound Fusion-Guided Prostate Biopsy and How is it Coded? https://community.auanet.org/blogs/policy-brief/2017/10/18/what-is-mri-with-transrectal-ultrasound-fusion-guided-prostate-biopsy-and-how-is-it-coded. Accessed 27 December 2019.

Titel: Imaging for prostate cancer: reimbursements
verfasst von: Connor Hoge
Abhinav Sidana
Sadhna Verma
Publikationsdatum: 20.02.2020
Verlag: Springer US
Erschienen in: Abdominal Radiology / Ausgabe 12/2020
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-020-02443-4

Neu im Fachgebiet Radiologie

23.04.2024 | Pankreaskarzinom | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Imaging for prostate cancer: reimbursements

Excerpt

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2020

Therapeutic response assessment in pancreatic ductal adenocarcinoma: society of abdominal radiology review paper on the role of morphological and functional imaging techniques

SAR Prostate Cancer Disease-Focused Panel report

PI-RADS: what is new and how to use it

Tips to start an MR-US fusion biopsy program

Extraprostatic extension in prostate cancer: primer for radiologists

Health disparities and inequities in the utilization of diagnostic imaging for prostate cancer

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie